Life sciences tools
The growth agency for life sciences tools and diagnostics.
Isovertic is the growth agency for healthcare, biotech, medical devices, and life sciences. This page is about life sciences tools and diagnostics: reagents, antibodies, kits, instruments, mouse models, cell lines, laboratory automation, and the diagnostics companies that sell into hospitals and reference labs. If your organization also has a therapeutic pipeline, a 510(k) or PMA device program, or a hospital-facing service line, our [biotech page](/industries/biotech), [medical devices page](/industries/medical-devices), and [healthcare page](/industries/healthcare) show what changes when the buyer is a VP of regulatory, a director of clinical affairs, or a practice administrator.
Chief scientific officers, founder-scientists, VP of commercial, product managers, laboratory directors, and principal investigators turned CEOs know the job is not "make us look scientific." You already are scientific. The job is to let the right researcher assess whether your reagent, antibody, kit, instrument, mouse model, cell line, in vitro diagnostic, or lab automation system belongs in the experiment they are planning.
The honest big thing is that researchers can spot a thin product page quickly. They need clone identity, species reactivity, validation context, assay compatibility, genotype, strain background, throughput, workflow, or performance information. The required detail changes by product. A vague promise does not make the page simpler. It makes the scientist leave and ask a colleague.
We build pages and programs that respect the research question and hand the commercial team a real conversation to follow up on. You will leave with a practical plan for publishing useful scientific material, connecting it to a meeting request, and keeping claims under control.
We have worked with many independent marketers and digital marketing companies over the years. All promised increased visibility and qualified leads to our site. Every single one fell short, until George Stoff's team at Isovertic. Not only was it easy to work with George, but his team delivered a 300% increase in qualified leads, so much so that we had to then create an automated response workflow to keep up with the demand. Excellent work, George! Highly recommended.
Start with Ground State at $2,500 per month. Move to Excitation at $5,000 per month plus advertising spend when the product page, offer, and response owner are ready. Pricing is published.
What you'll take away
- How to help a researcher find the evidence, protocol context, and commercial next step without overselling the result.
- Why reagents, antibodies, kits, instruments, mouse models, cell lines, in vitro diagnostics, and lab automation need different proof.
- What the Ingenious Targeting Laboratory account results show about useful scientific pages and responsive follow-up.
- How a chief scientific officer, laboratory director, and VP of commercial can share one operating record without flattening scientific nuance.
- Which package is the right starting point for a founder-scientist, product manager, or principal investigator turned CEO.
What actually breaks in life sciences tools and diagnostics marketing
The product page stops before the experiment begins
An antibody page that omits validation context or an instrument page that never addresses workflow leaves the scientist to assemble the answer elsewhere. The reader may still be interested. They are simply not ready to spend time explaining the basics to a sales form.
One voice for every product category
Reagents and kits invite questions about protocol fit. Mouse models raise questions about genotype, background strain, phenotype, colony status, and study design. Cell lines need authentication and culture context. In vitro diagnostics need intended-use and performance discipline. Lab automation calls for throughput, integration, and failure-handling detail. One generic structure makes all of them feel generic.
Scientific evidence and commercial follow-up do not meet
A product manager may have excellent technical documentation while the VP of commercial sees a form submission with no context. The handoff needs to retain the product, application, model, assay, and question the researcher expressed, without asking the scientist to complete a dissertation before they can talk to someone.
A successful inquiry waits too long
Researchers often reach out near an experiment deadline, procurement decision, grant milestone, or animal-study planning window. A response that arrives days later can still be polite and still be useless. The team needs a named owner and a one-business-day response commitment.
What we do differently for life sciences tools and diagnostics
Evidence discipline by product type
We establish the product facts and source material before drafting. For antibodies, that may include clone, target, species reactivity, application, and validation. For kits, it may include inputs, workflow, controls, readout, and limitations. For instruments and lab automation, it may include throughput, sample types, integration, training, and service. For mouse models and cell lines, it may include genotype, background, authentication, handling, and study context. The page answers the question the researcher actually brought.
A clear route from scientific question to human answer
We have a method for deciding what to publish and how to direct paid activity. We do not publish that method. The resulting pages give researchers enough substance to judge fit, then offer a sensible next step: speak to a scientist, request a quote, ask about a model, or plan an evaluation. The commercial team receives the question with its context instead of a bare email address.
Claim review sized to the product
Most research-use tools do not require the same review process as a regulated therapeutic. But "research use only," analytical performance, clinical performance, and intended-use language still deserve care. For an in vitro diagnostic, we keep product statements within the device's authorized status and source set, informed by FDA's 510(k) pathway and PMA pathway materials, and we route them through your regulatory reviewer. For general research tools, we maintain an evidence record so a product manager can correct a statement before it becomes tomorrow's sales slide.
Programs that serve the researcher and the commercial team
A founder-scientist or laboratory director may need technical credibility while a VP of commercial needs meetings. Those goals are compatible if the work starts with real scientific questions. We publish useful material on cadence, send it to your list, and use paid activity only where the product and intake path are ready. Each month, the reporting records what was published, how it performed, and what the team needs to answer next.
Follow-up that treats the inquiry as a scientific conversation
Ground State creates the foundation. Excitation adds one campaign and a one-business-day response commitment. We help assign that response to the correct person: an application scientist, product manager, commercial lead, or founder. The goal is not to make every inquiry identical. It is to make sure a serious question reaches someone who can answer it.
What actually shows up each month
Every package includes named deliverables, not strategy. On Ground State at $2,500 per month, each month you get one published article on your site, one newsletter to your list, eight social posts, one short monthly report, and the website rebuild and hosting spread across the year. On Excitation at $5,000 per month plus advertising spend, you also get one managed Google Ads campaign, one campaign landing page refreshed as needed, 16 social posts, a one-business-day inbound response commitment, and a monthly strategy call with the account lead. See every package and add-on on the pricing page.
Proof, before the pitch
Ingenious Targeting Laboratory, a mouse-model company selling to research scientists and principal investigators, moved from 13 monthly form submissions to about 64 in its first eight months with Isovertic. Its organic search traffic rose 3.7 times in that period. Internal, September 2026. Those figures are internal operating results for one account. They are not a guarantee and they do not tell us which other company will see the same pattern.
What makes the story useful is the fit between material and audience. A researcher looking for an animal model needs more than a broad company description. They need to see whether the model, gene knockout, humanized mouse, phenotype, breeding plan, and service support the study. The account gave those questions a place to land, then gave the team an inquiry record it could use.
For a reagents company, the relevant questions may be assay compatibility and validation. For a lab automation company, they may be throughput and integration. For an in vitro diagnostic company, the commercial language requires a more formal review path. The operating approach remains the same: useful scientific material, a clear handoff, timely response, and an account record that distinguishes real opportunity from general interest.
The package you'd probably start on
Start with Ground State at $2,500 per month. It includes a website rebuild across the year, one published article per month, one newsletter, eight social posts, hosting, and a short monthly report. It is a 12-month engagement. For a founder-scientist or early commercial team, Ground State creates the evidence library and publishing rhythm before adding more activity.
Move to Excitation at $5,000 per month plus advertising spend when the product page, offer, and response owner are ready. It adds one managed Google Ads campaign, a campaign page, 16 social posts, a monthly strategy call, and a one-business-day inbound response commitment. Google says search improvements may take four months to a year. That is why we report early operating signals every 30 days and review pipeline and revenue at months six and 12.
The honest limits
We cannot manufacture a validation study, make a product fit an experiment it does not fit, or fix an unreliable supply chain. We cannot replace a thoughtful applications scientist in a technical conversation. We can make the evidence easier to find, the inquiry easier to route, and the commercial follow-up easier to run.
Scientific content is reviewed by a molecular biologist on staff before it ships to a client's MLR reviewer. That review catches the small terminology mistakes that would waste a reviewer's cycle and delay a launch by a week.
What founders ask first
A molecular biologist on staff reviews life-science work before it reaches a client's reviewer. We write from your product facts, validation, and the questions researchers actually ask.
No. Biotech covers therapeutics and translational programs. This page is for reagents, instruments, mouse models, cell lines, lab automation, and diagnostics sold into labs and hospitals.
Revenue is reviewed against the real sales cycle at month six and month twelve, while the early scorecard reports what was published, how it performed, and what the team needs to answer next.
Send us your best-converting landing page or current product page.
If you would rather talk it through, book a pipeline call and send us your best-converting landing page or current product page. In about ten minutes we will tell you what is unclear, whether the fix is a revised product page or a larger rebuild, and what a rebuild would cost, or whether you need one at all. Sometimes the honest answer is you are already fine, and we are happy to say so and hand you back your afternoon.
George Stoff, Founder and Lead Engineer
Full-stack engineer with more than 30 years building the systems companies sell through. He built the method Isovertic runs on and stays on every account as the standards owner and the escalation path. When search algorithms shift or a compliance question comes up, you get his engineering judgment. Day-to-day execution runs on the team he trained.
LinkedInKristen Coughlin, Chief Operating Officer
Trained molecular biologist. Ten years selling translational research products, then institutional operations in the Department of Microbial Pathogenesis at the Yale School of Medicine. She reviews life-science work before it reaches a client's medical, legal, and regulatory reviewer. She also built the delivery operation: took the method George engineered, wrote it down, trained the team on it, and turned it into a repeatable engagement so the same system runs the same way on every account.
LinkedIn